Science & Enterprise subscription

Follow us on Twitter

  • A group of Canadian academic labs and hospitals will begin a clinical trial testing antibodies from recovered Covid… https://t.co/BsfaYEhTGM
    about 4 hours ago
  • New post on Science and Enterprise: Trial to Test Convalescent Antibodies for Covid-19 https://t.co/tWxVos72rq #Science #Business
    about 4 hours ago
  • A company developing cancer immunotherapies is adapting its electronic-assisted process to create a vaccine protect… https://t.co/4Xg2tQlV57
    about 1 day ago
  • New post on Science and Enterprise: Trial to Test Electronic-Aided Covid-19 Vaccine https://t.co/RPHi8QpchO #Science #Business
    about 1 day ago
  • An industry group says rules for loans to small companies hard-hit by Covid-19 are changed to allow these loans for… https://t.co/k8OZb84rcC
    about 1 day ago

Please share Science & Enterprise

Trial to Test Electronic-Aided Covid-19 Vaccine

SARS-Cov-2 virus

A company developing cancer immunotherapies is adapting its electronic-assisted process to create a vaccine protecting against Covid-19 infections. . . . → Read More: Trial to Test Electronic-Aided Covid-19 Vaccine

Employers, Patients See Discounts from Biosimilars

Pills and dollar bill

An analysis of health care spending by large employers shows both companies and their employees are saving money from using non-branded biologic therapies. . . . → Read More: Employers, Patients See Discounts from Biosimilars

Life Science Venture Funds Raise $2.56B for Start-Ups

Investment graphic

Two investment companies specializing in health care and life sciences revealed new venture funds to finance young enterprises with innovative technologies. . . . → Read More: Life Science Venture Funds Raise $2.56B for Start-Ups

Trial Shows Rare Disease Drug Treats Covid-19 Patients

Covid-19 illustration

Results from a clinical trial show a drug approved for a rare lymph node disease can stabilize or improve the condition of many people with severe Covid-19 complications. . . . → Read More: Trial Shows Rare Disease Drug Treats Covid-19 Patients

Start-Up Licenses Immunotherapies in $880M Deal

Human T-cell

A new biotechnology enterprise creating treatments that alter chemical functions in immune cells agreed to license its technology to a pharmaceutical company. . . . → Read More: Start-Up Licenses Immunotherapies in $880M Deal

Biotechs Explore Cell Therapy for Covid-19 Antibodies

Coronavirus face mask

Two biotechnology companies are researching use of a non-viral gene therapy to deliver synthetic antibodies for treating Covid-19 infections. . . . → Read More: Biotechs Explore Cell Therapy for Covid-19 Antibodies

Sanofi, Biotech Partner on RNA Covid-19 Vaccine

SARS-Cov-2 virus

Drug maker Sanofi and biotechnology company Translate Bio are creating a new vaccine to protect against the virus causing Covid-19 infections . . . → Read More: Sanofi, Biotech Partner on RNA Covid-19 Vaccine

Venture Fund to Back Covid-19 Start-Ups

Caspr Biotech

A life science incubator company plans to fund eight start-up enterprises developing diagnostics, vaccines, or treatments for the Covid-19 pandemic. . . . → Read More: Venture Fund to Back Covid-19 Start-Ups

Trial to Test Arthritis Drug for Covid-19 Pneumonia

Human lungs illustration

A clinical trial is beginning soon that tests a current drug for rheumatoid arthritis as a treatment for severe pneumonia in patients with Covid-19 infections. . . . → Read More: Trial to Test Arthritis Drug for Covid-19 Pneumonia

Engineered Blood Cells Created for Cancer Therapies

Macrophage

An academic lab and spin-off company are developing engineered white blood cells with added cancer-killing proteins to attack solid tumor cancers. . . . → Read More: Engineered Blood Cells Created for Cancer Therapies